Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
DXCM [NASD]
DexCom, Inc.
Index- P/E- EPS (ttm)-0.36 Insider Own2.50% Shs Outstand76.56M Perf Week-4.48%
Market Cap3.86B Forward P/E- EPS next Y-0.01 Insider Trans-11.92% Shs Float74.92M Perf Month14.27%
Income-26.30M PEG- EPS next Q-0.04 Inst Own99.50% Short Float5.95% Perf Quarter14.71%
Sales226.60M P/S17.02 EPS this Y46.80% Inst Trans3.44% Short Ratio7.03 Perf Half Y45.75%
Book/sh1.52 P/B33.14 EPS next Y97.20% ROA-19.20% Target Price51.88 Perf Year53.71%
Cash/sh0.98 P/C51.49 EPS next 5Y32.50% ROE-27.10% 52W Range28.09 - 54.50 Perf YTD42.25%
Dividend- P/FCF676.55 EPS past 5Y26.80% ROI-31.80% 52W High-7.58% Beta0.41
Dividend %- Quick Ratio2.70 Sales past 5Y74.80% Gross Margin66.60% 52W Low79.32% ATR1.74
Employees646 Current Ratio3.00 Sales Q/Q60.80% Oper. Margin-11.20% RSI (14)60.02 Volatility2.65% 3.35%
OptionableYes Debt/Eq0.05 EPS Q/Q12.50% Profit Margin-11.60% Rel Volume1.16 Prev Close50.85
ShortableYes LT Debt/Eq0.03 EarningsNov 06 AMC Payout- Avg Volume633.80K Price50.37
Recom2.00 SMA204.45% SMA5014.23% SMA20024.22% Volume738,002 Change-0.94%
Aug-07-14Reiterated Canaccord Genuity Buy $40 → $48
Jun-17-14Reiterated Canaccord Genuity Buy $38 → $40
Jan-24-14Resumed Canaccord Genuity Buy $34 → $44
Jan-14-14Reiterated The Benchmark Company Buy $40 → $44
Nov-07-13Upgrade Northland Capital Under Perform → Market Perform
Oct-15-13Initiated The Benchmark Company Buy $37
Aug-12-13Reiterated Feltl & Co. Sell $16.50 → $18.25
Aug-08-13Reiterated Canaccord Genuity Buy $25 → $26
Jul-24-13Downgrade Northland Capital Outperform → Under Perform $17
Jun-13-13Downgrade Feltl & Co. Hold → Sell
Jun-10-13Downgrade Wunderlich Buy → Hold $20
Mar-13-13Reiterated Wunderlich Buy $18 → $20
Feb-25-13Reiterated Feltl & Co. Hold $14 → $15.50
Jan-14-13Reiterated Wunderlich Buy $15 → $18
Oct-18-12Initiated Northland Securities Market Perform $12
Jan-17-12Initiated Brean Murray Buy $12.50
Jan-11-12Downgrade MLV & Co Buy → Hold $9
Dec-29-11Initiated Wunderlich Buy $12
Dec-20-11Initiated MLV & Co Buy $11
Oct-28-11Downgrade Feltl & Co. Buy → Hold
Nov-19-14 08:30AM  DEXCOM INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events EDGAR Online
08:30AM  DexCom Announces Appointment of Mark G. Foletta as Board Member Business Wire
Nov-14-14 01:04PM  DEXCOM INC Financials EDGAR Online Financials
Nov-11-14 01:10PM  DexCom Scales 52-Week High on Product Pipeline Strength Zacks
Nov-10-14 01:54PM  DexCom G4 Platinum Software Gains FDA Nod, Shares Surge Zacks +5.05%
06:36AM  Strength Seen in DexCom (DXCM): Stocks Gains 14.1% Zacks
Nov-08-14 07:07PM  10-Q for DexCom, Inc. Company Spotlight
Nov-07-14 06:06AM  Foundation Medicine Slumps: FMI Tumbles 9.6% in Session Zacks +14.12%
Nov-06-14 04:52PM  DexCom misses 3Q profit forecasts AP
04:07PM  DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:01PM  DexCom, Inc. Reports Third Quarter 2014 Financial Results Business Wire
08:30AM  FDA Approves Dexcom Software with Artificial Pancreas Algorithm Business Wire
07:07AM  Q3 2014 DexCom Inc Earnings Release - After Market Close CCBN
Oct-30-14 08:30AM  DexCom Announces Upcoming Conference Presentations Business Wire
Oct-23-14 08:30AM  DexCom Schedules Third Quarter 2014 Earnings Release and Conference Call for November 6, 2014 at 4:30 p.m. Eastern Time Business Wire
Oct-20-14 02:19PM  [$$] Dexcom's Remote Glucose-Monitoring Device Cleared at The Wall Street Journal
09:24AM  FDA Approves Dexcom SHARE, the First Remote Mobile Communications Device Used for Continuous Glucose Monitoring (CGM) Business Wire
Oct-06-14 05:03PM  DEXCOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
Sep-27-14 12:06AM  [$$] Citizen Hackers Tinker With Medical Devices at The Wall Street Journal
Sep-26-14 07:19PM  [$$] Citizen Hackers Tinker With Medical Devices at The Wall Street Journal
05:31PM  [video] Citizen Hackers Modify Diabetes Device at MarketWatch
Sep-03-14 01:04PM  3 Stocks Dragging The Health Services Industry Downward at TheStreet
11:15AM  Insider Trading Alert - NATI, DXCM And CNC Traded By Insiders at TheStreet
Aug-25-14 05:50PM  [video] A sensor to swallow with your medicine at CNBC
Aug-22-14 04:05PM  Top Insider Sells Highlight: Dexcom Inc. Gurufocus
Aug-21-14 01:04PM  DXCM, HOLX And CYH, Pushing Health Services Industry Downward at TheStreet
Aug-14-14 12:00PM  DexCom Continues to Gain; Enters Data Integration Deal Zacks
Aug-07-14 11:10AM  DexCom Sees Narrower Q2 Loss; Revenues Top Estimates Zacks +13.61%
09:47AM  Trade-Ideas: DexCom (DXCM) Is Today's "Barbarian At The Gate" Stock at TheStreet
08:30AM  Dexcom Announces Data Integration Relationship with Asante Solutions, Makers of the Snap Insulin Pump Business Wire
Aug-06-14 04:30PM  DexCom Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:06PM  DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:01PM  DexCom, Inc. Reports Second Quarter 2014 Financial Results Business Wire
07:07AM  Q2 2014 DEXCOM INC Earnings Release - After Market Close CCBN
Aug-05-14 04:05PM  Insulet and Dexcom Agree to Develop a CGM-Integrated Personal Diabetes Manager Marketwired
Aug-01-14 12:05PM  Jay D. Miller, the President and CEO of IMRIS Inc. (IMRS), Interviews with The Wall Street Transcript Wall Street Transcript
Jul-31-14 08:30AM  DexCom to Present at Canaccord Genuity 34th Annual Growth Conference Business Wire -6.06%
06:00AM  'Mad Money' Lightning Round: Stay With Thermo Fisher Scientific at TheStreet
Jul-23-14 08:30AM  DexCom Schedules Second Quarter 2014 Earnings Release and Conference Call for August 6, 2014 at 4:30 p.m. Eastern Time Business Wire
Jul-18-14 01:10PM  5 New Medical Technologies For Diabetics Benzinga
Jul-07-14 08:30AM  DEXCOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
Jun-16-14 02:30PM  DexCom Collaborates with Insulet Corporation Zacks +5.08%
12:00AM  Freedom for Diabetics as Bionic Pancreas Passes Testing at Bloomberg
Jun-15-14 09:00PM  Diabetics Get Freedom in Bionic Pancreas Real-World Trial at Bloomberg
Jun-13-14 04:01PM  DexComs Forthcoming Mobile App Platform to Integrate Data from Insulets OmniPod System Business Wire
Jun-05-14 09:17AM  Top Swing Trade Ideas for Thursday, June 5: DexCom, Conn's and More at TheStreet
Jun-04-14 05:15PM  [video] Health app space heats up at CNBC +7.06%
12:50PM  FDA Nod for DexCom's G4 PLATINUM System Zacks
08:30AM  DEXCOM INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Jun-03-14 04:01PM  The first and only real-time professional CGM, the Dexcom G4® PLATINUM Professional Continuous Glucose Monitoring System (CGM) Receives FDA Approval Business Wire
May-27-14 08:30AM  DexCom Announces Upcoming Conference Presentations Business Wire
May-16-14 03:55PM  Why Jim Cramer Says Investors Should Watch DexCom (DXCM) Stock at TheStreet
11:45AM  [video] Jim Cramer on Why DexCom Could be a Good Portfolio Addition at TheStreet
11:37AM  The Bellwether We've Searched For at TheStreet
May-12-14 10:27AM  DexCom has a conference call hosted by JPMorgan at theflyonthewall.com
May-06-14 08:32AM  DexCom Misses, Sees Broader Q1 Loss Zacks
May-02-14 02:11PM  Why DexCom Inc. Shares Briefly Swooned at Motley Fool
May-01-14 08:55PM  DexCom's CEO Discusses Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  DEXCOM INC Earnings Call scheduled for 4:30 pm ET today CCBN
04:25PM  DexCom, Inc. Discusses Q1 2014 Results (Webcast) at Seeking Alpha
04:09PM  DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:01PM  DexCom, Inc. Reports First Quarter 2014 Financial Results Business Wire
07:07AM  Q1 2014 DEXCOM INC Earnings Release - After Market Close CCBN
Apr-30-14 03:37PM  5 stocks to watch at MarketWatch
08:30AM  DexCom Announces Upcoming Conference Presentations Business Wire
Apr-24-14 08:30AM  DexCom Schedules First Quarter 2014 Earnings Release and Conference Call for May 1, 2014 at 4:30 p.m. Eastern Time Business Wire
Apr-16-14 01:09PM  1 Stock Helping Revolutionize Diabetes Monitoring at Motley Fool +5.47%
Apr-15-14 06:46PM  Lightning Round: Delta, LinkedIn & More at CNBC
Apr-10-14 01:50PM  Delcath Systems Shares Tank on Stock Split Zacks -5.83%
09:50AM  Why DexCom (DXCM) Stock Is Higher Today at TheStreet
08:10AM  Top Analyst Upgrades and Downgrades: Apple, EMC, Facebook, Twitter, IBM , AcelRx and More at 24/7 Wall St.
08:10AM  Top Analyst Upgrades and Downgrades: Apple, EMC, Facebook, Twitter, IBM , AcelRx and More 24/7 Wall St.
05:54AM  DexCom upgraded to Buy from Neutral at Sterne Agee theflyonthewall.com
Apr-08-14 07:56AM  DexCom (DXCM) is now in Oversold Territory Zacks
Apr-03-14 02:30PM  DexCom Shares Fall on FDA Warning Zacks
Apr-01-14 01:50PM  Balanced View on Haemonetics Zacks
Mar-31-14 01:50PM  Balanced View on Hologic Zacks
Mar-25-14 04:02PM  Should You Buy DexCom After The Meteoric Rise? at Seeking Alpha
09:32AM  [$$] Suicide Banker Feared Investigation at The Wall Street Journal
08:30AM  DexCom Receives FDA Warning Letter for Administrative Deficiencies in its MDR Reporting Business Wire
Mar-24-14 07:12AM  Why DexCom (DXCM) Could Be a Potential Winner Zacks
Mar-05-14 04:04PM  Dexcom Supports NASCAR Driver Ryan Reeds American Diabetes Association Drive to Stop Diabetes Initiative Business Wire
Mar-04-14 06:23AM  Is DexCom (DXCM) a Great Growth Stock? Zacks
Feb-28-14 11:45AM  Insider Trading Alert - WAB, DXCM And CMCSA Traded By Insiders at TheStreet
Feb-25-14 08:40AM  DexCom Beats, Sees Narrower Q4 Loss Zacks
08:30AM  DexCom Announces Upcoming Conference Presentations Business Wire
Feb-21-14 07:54AM  DexCom price target raised to $50 from $45 at Stephens at theflyonthewall.com
Feb-20-14 08:56PM  DexCom's CEO Discusses Q4 2013 Results - Earnings Call Transcript Optionetics
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. It offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. The company's ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments, as well as DexCom SHARE, a remote monitoring system, which provides secondary notification and does not replace real time continuous glucose monitoring or standard home blood glucose monitoring. Its in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. The company also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. It markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. The company was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GREGG TERRANCE HCEONov 19Option Exercise8.9510,00089,500405,626Nov 21 05:46 PM
GREGG TERRANCE HCEONov 19Sale51.0010,000510,000395,626Nov 21 05:46 PM
GREGG TERRANCE HCEONov 17Option Exercise6.8525,000171,250420,626Nov 18 06:12 PM
GREGG TERRANCE HCEONov 17Sale52.5225,0001,313,063395,626Nov 18 06:12 PM
GREGG TERRANCE HCEONov 17Sale52.5210,000525,225610,389Nov 18 06:12 PM
GREGG TERRANCE HCEONov 14Option Exercise8.9510,00089,500405,626Nov 18 06:12 PM
GREGG TERRANCE HCEONov 14Sale52.5110,000525,083395,626Nov 18 06:12 PM
GREGG TERRANCE HCEONov 12Option Exercise8.9525,000223,750420,626Nov 13 05:58 PM
LISTER JOHNSr. VP, General CounselNov 12Option Exercise4.581,7508,015110,425Nov 14 04:54 PM
GREGG TERRANCE HCEONov 12Sale54.0125,0001,350,350395,626Nov 13 05:58 PM
LISTER JOHNSr. VP, General CounselNov 12Sale52.813,078162,560107,347Nov 14 04:54 PM
LORD JONATHAN T MDDirectorNov 11Option Exercise7.7818,058140,491155,165Nov 13 04:53 PM
MOY JEFFREYSVP, OperationsNov 11Option Exercise9.804,00039,20086,292Nov 13 05:38 PM
ROPER JESSVP, CFONov 11Option Exercise7.6320,000152,600103,342Nov 13 05:45 PM
Balo Andrew KSVP, Regulatory and ClinicalNov 11Option Exercise7.6310,00076,300160,130Nov 13 05:51 PM
GREGG TERRANCE HCEONov 11Option Exercise8.9555,000492,250450,626Nov 13 05:58 PM
LORD JONATHAN T MDDirectorNov 11Sale53.0918,058958,609137,107Nov 13 04:53 PM
MOY JEFFREYSVP, OperationsNov 11Sale53.004,000212,00082,292Nov 13 05:38 PM
ROPER JESSVP, CFONov 11Sale52.9320,0001,058,54083,342Nov 13 05:45 PM
Balo Andrew KSVP, Regulatory and ClinicalNov 11Sale52.9310,000529,295150,130Nov 13 05:51 PM
GREGG TERRANCE HCEONov 11Sale53.0655,0002,918,465395,626Nov 13 05:58 PM
VALDES JORGE ACTONov 10Option Exercise7.2516,000116,000134,748Nov 12 03:19 PM
VALDES JORGE ACTONov 10Sale51.2316,000819,706118,748Nov 12 03:19 PM
Balo Andrew KSVP, Regulatory and ClinicalOct 27Option Exercise7.6310,00076,300160,130Oct 28 08:27 PM
Balo Andrew KSVP, Regulatory and ClinicalOct 27Sale42.9810,000429,755150,130Oct 28 08:27 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesOct 23Option Exercise6.034,00024,120123,950Oct 24 05:13 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesOct 23Sale43.584,000174,310119,950Oct 24 05:13 PM
ROPER JESSVP, CFOOct 20Option Exercise7.638,00061,04091,342Oct 21 07:53 PM
ROPER JESSVP, CFOOct 20Sale41.188,000329,46383,342Oct 21 07:53 PM
GREGG TERRANCE HCEOOct 15Option Exercise6.8525,000171,250420,626Oct 16 08:02 PM
GREGG TERRANCE HCEOOct 15Sale39.6325,000990,693395,626Oct 16 08:02 PM
GREGG TERRANCE HCEOOct 15Sale39.6310,000396,277620,389Oct 16 08:02 PM
LISTER JOHNSr. VP, General CounselOct 13Option Exercise4.581,7508,015112,075Oct 14 06:21 PM
LISTER JOHNSr. VP, General CounselOct 13Sale40.413,400137,405108,675Oct 14 06:21 PM
VALDES JORGE ACTOOct 08Option Exercise7.2516,000116,000134,748Oct 10 05:09 PM
VALDES JORGE ACTOOct 08Sale40.2916,000644,651118,748Oct 10 05:09 PM
Balo Andrew KSVP, Regulatory and ClinicalSep 25Option Exercise7.6310,00076,300160,130Sep 25 08:30 PM
Balo Andrew KSVP, Regulatory and ClinicalSep 25Sale40.7110,000407,072150,130Sep 25 08:30 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Sep 23Option Exercise7.6314,000106,820242,866Sep 24 06:42 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesSep 23Option Exercise6.034,00024,120123,950Sep 24 06:43 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Sep 23Sale40.3214,000564,483228,866Sep 24 06:42 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesSep 23Sale40.324,000161,262119,950Sep 24 06:43 PM
ROPER JESSVP, CFOSep 18Option Exercise7.688,00061,44088,842Sep 18 06:38 PM
ROPER JESSVP, CFOSep 18Sale41.918,000335,30683,342Sep 18 06:38 PM
LISTER JOHNSr. VP, General CounselSep 15Option Exercise4.585,50025,190110,325Sep 15 08:57 PM
GREGG TERRANCE HCEOSep 15Option Exercise6.8525,000171,250420,626Sep 17 06:59 PM
GREGG TERRANCE HCEOSep 15Sale41.1425,0001,028,555395,626Sep 17 06:59 PM
GREGG TERRANCE HCEOSep 15Sale41.1410,000411,422630,389Sep 17 06:59 PM
LISTER JOHNSr. VP, General CounselSep 12Option Exercise4.581,7508,015106,575Sep 15 08:57 PM
LISTER JOHNSr. VP, General CounselSep 12Sale43.703,518153,739104,825Sep 15 08:57 PM
Balo Andrew KSVP, Regulatory and ClinicalSep 11Option Exercise7.6310,00076,300164,116Sep 12 08:02 PM
Balo Andrew KSVP, Regulatory and ClinicalSep 11Sale42.9710,000429,706154,534Sep 12 08:02 PM
VALDES JORGE ACTOSep 08Option Exercise3.1916,00051,040158,621Sep 10 07:42 PM
VALDES JORGE ACTOSep 08Sale42.9816,000687,736142,621Sep 10 07:42 PM
KAHN BARBARADirectorAug 28Sale44.524,000178,09249,525Sep 02 06:15 PM
LORD JONATHAN T MDDirectorAug 26Option Exercise7.7820,000155,600157,107Aug 28 05:32 PM
MOY JEFFREYSVP, OperationsAug 26Option Exercise8.4116,663140,177107,916Aug 28 05:32 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Aug 26Option Exercise20.6516,000330,400257,399Aug 27 05:57 PM
GREGG TERRANCE HCEOAug 26Sale46.055,000230,267640,389Aug 28 05:31 PM
LORD JONATHAN T MDDirectorAug 26Sale45.5620,000911,240137,107Aug 28 05:32 PM
MOY JEFFREYSVP, OperationsAug 26Sale45.3016,663754,83597,916Aug 28 05:32 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Aug 26Sale44.8516,000717,523241,399Aug 27 05:57 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Aug 25Option Exercise7.6314,000106,820255,399Aug 27 05:57 PM
Balo Andrew KSVP, Regulatory and ClinicalAug 25Option Exercise7.6310,00076,300169,205Aug 27 05:59 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesAug 25Option Exercise6.034,00024,120130,582Aug 27 05:58 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Aug 25Sale44.2414,000619,338241,399Aug 27 05:57 PM
Balo Andrew KSVP, Regulatory and ClinicalAug 25Sale44.1210,000441,243159,205Aug 27 05:59 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesAug 25Sale44.354,000177,406126,582Aug 27 05:58 PM
GREGG TERRANCE HCEOAug 22Option Exercise6.856,10741,833401,733Aug 25 05:14 PM
Balo Andrew KSVP, Regulatory and ClinicalAug 22Option Exercise3.1920,00063,800179,205Aug 25 05:13 PM
GREGG TERRANCE HCEOAug 22Sale44.586,107272,242395,626Aug 25 05:14 PM
GREGG TERRANCE HCEOAug 22Sale44.367,500332,672645,389Aug 25 05:14 PM
Balo Andrew KSVP, Regulatory and ClinicalAug 22Sale44.2420,000884,722159,205Aug 25 05:13 PM
KAHN BARBARADirectorAug 21Sale43.422,20095,52453,525Aug 21 07:49 PM
VALDES JORGE ACTOAug 21Sale43.5810,671465,04064,195Aug 25 05:15 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesAug 19Option Exercise9.8020,000196,000146,582Aug 20 08:08 PM
GREGG TERRANCE HCEOAug 19Option Exercise5.6775,000424,950430,626Aug 20 08:11 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesAug 19Sale45.0120,000900,278126,582Aug 20 08:08 PM
GREGG TERRANCE HCEOAug 19Sale45.0875,0003,380,782395,626Aug 20 08:11 PM
GREGG TERRANCE HCEOAug 18Option Exercise7.0565,000458,450420,626Aug 20 08:11 PM
GREGG TERRANCE HCEOAug 18Sale44.1665,0002,870,580395,626Aug 20 08:11 PM
GREGG TERRANCE HCEOAug 18Sale44.0410,000440,448652,889Aug 20 08:11 PM
GREGG TERRANCE HCEOAug 15Option Exercise6.855,00034,250400,626Aug 19 06:25 PM
GREGG TERRANCE HCEOAug 15Sale44.065,000220,291395,626Aug 19 06:25 PM
GREGG TERRANCE HCEOAug 14Option Exercise7.2725,000181,750415,626Aug 15 05:13 PM
GREGG TERRANCE HCEOAug 14Sale44.2425,0001,105,944395,626Aug 15 05:13 PM
GREGG TERRANCE HCEOAug 13Option Exercise6.5838,607254,112411,734Aug 14 06:52 PM
GREGG TERRANCE HCEOAug 13Sale43.7938,6071,690,527395,626Aug 14 06:52 PM
LISTER JOHNSr. VP, General CounselAug 12Option Exercise4.581,7508,015114,305Aug 14 06:51 PM
GREGG TERRANCE HCEOAug 12Option Exercise8.9517,500156,625413,126Aug 14 06:52 PM
LISTER JOHNSr. VP, General CounselAug 12Sale43.683,353146,455112,555Aug 14 06:51 PM
GREGG TERRANCE HCEOAug 12Sale43.0917,500754,056395,626Aug 14 06:52 PM
Balo Andrew KSVP, Regulatory and ClinicalAug 11Option Exercise8.9410,00089,400169,205Aug 12 05:44 PM
SAYER KEVIN RPresident & COOAug 11Sale43.8220,000876,492424,924Aug 15 05:12 PM
Balo Andrew KSVP, Regulatory and ClinicalAug 11Sale44.2410,000442,373159,205Aug 12 05:44 PM
VALDES JORGE ACTOAug 08Option Exercise3.1916,00051,040233,487Aug 12 05:45 PM
VALDES JORGE ACTOAug 08Sale43.5616,000697,006217,487Aug 12 05:45 PM
Balo Andrew KSVP, Regulatory and ClinicalJul 25Option Exercise8.9410,00089,400169,099Jul 29 07:07 PM
Balo Andrew KSVP, Regulatory and ClinicalJul 25Sale38.1910,000381,857159,099Jul 29 07:07 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jul 23Option Exercise7.6314,000106,820255,399Jul 24 05:49 PM